Sales enablement for enterprise revenue teams for healthcare and life sciences in Latin America

This edition of the Growth Broker playbook is written for commercial leaders at healthtech, medtech, and life-sciences companies operating in Latin America. In this market, LATAM buyers reward hands-on partnership, local presence, and clear commercial terms, so the way you install sales enablement has to be shaped to that reality from day one.

Enterprise sales enablement is not a bigger version of the startup playbook. It is putting the exact asset a rep needs in front of the exact deal at the exact stage, run under governance, procurement, and regional constraints most founders never encounter.

The value of sales enablement at enterprise scale is compounded by distribution: reps waste 25% of the week hunting for content, and applied across dozens of teams the delta becomes a full quarter of pipeline.

The right shape at enterprise is a hub-and-spoke: a central team owns the model, the metric, and the tooling; regional teams own execution against local ICP nuance. Fully centralised deployments miss context; fully federated deployments diverge inside a quarter.

Inside healthcare and life sciences, the binding constraint is almost always regulated-sale cycle length, not intent, and in Latin America it is compounded by the fact that local partnership depth, not marketing spend is what actually gates growth. Sales enablement is only useful here when it is pointed at both constraints at once.

Instrument ramp time for new reps to first closed-won as a shared metric across BUs before you argue about incentives. Anything less turns the operating review into a data debate instead of a revenue conversation.

The enterprise-specific failure mode is content libraries no one opens, magnified by the fact that governance rewards process compliance over outcome. Design controls that catch the trap without slowing the model.

Rollout takes two quarters, not two months. Pilot with one BU that already has strong ops. Publish a scorecard. Then expand — never in parallel across five regions at once.

Enterprise sales enablement done right is the difference between a decade of predictable growth and a decade of restructures. Done wrong, it becomes another initiative buried under next year's slide.

Concretely for healthcare and life sciences in Latin America: the healthcare teams that install this get past procurement instead of dying in it, and one properly-installed LATAM account becomes a reference across the region. That is the reason it is worth installing sales enablement deliberately for this market rather than importing a playbook designed for somewhere else.